6 institutions reported holding $2.1M of ARS PHARMACEUTIC (SPRY) in SEC 13F filings for 2026-06-30. Largest institutional holders: Hennion & Walsh Asset Management, Inc. ($1.4M), Norman Fields, Gottscho Capital Management, LLC ($569,351), CX Institutional ($67,000), GAMMA Investing LLC ($10,061), Versant Capital Management, Inc ($7,938). Source: SEC Form 13F.
| Rank | Institution | Value | Shares | Change |
|---|---|---|---|---|
| 1 | Hennion & Walsh Asset Management, Inc. | $1.4M | 175,614 | New |
| 2 | Norman Fields, Gottscho Capital Management, LLC | $569,351 | 71,080 | Added |
| 3 | CX Institutional | $67,000 | 8,390 | Trimmed |
| 4 | GAMMA Investing LLC | $10,061 | 1,256 | Added |
| 5 | Versant Capital Management, Inc | $7,938 | 991 | Trimmed |
| 6 | EASTERN BANK | $0 | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30